DE2203584A1 - Arzneimittel zur Bekaempfung der Parkinsonschen Krankheit - Google Patents

Arzneimittel zur Bekaempfung der Parkinsonschen Krankheit

Info

Publication number
DE2203584A1
DE2203584A1 DE19722203584 DE2203584A DE2203584A1 DE 2203584 A1 DE2203584 A1 DE 2203584A1 DE 19722203584 DE19722203584 DE 19722203584 DE 2203584 A DE2203584 A DE 2203584A DE 2203584 A1 DE2203584 A1 DE 2203584A1
Authority
DE
Germany
Prior art keywords
dopa
disease
oxazolidinone
combination
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19722203584
Other languages
German (de)
English (en)
Inventor
Plotnikoff Nicholas Peter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of DE2203584A1 publication Critical patent/DE2203584A1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DE19722203584 1971-01-27 1972-01-26 Arzneimittel zur Bekaempfung der Parkinsonschen Krankheit Pending DE2203584A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11025371A 1971-01-27 1971-01-27

Publications (1)

Publication Number Publication Date
DE2203584A1 true DE2203584A1 (de) 1972-08-03

Family

ID=22332021

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19722203584 Pending DE2203584A1 (de) 1971-01-27 1972-01-26 Arzneimittel zur Bekaempfung der Parkinsonschen Krankheit

Country Status (6)

Country Link
US (1) US3686409A (enExample)
AU (1) AU461236B2 (enExample)
CA (1) CA964582A (enExample)
DE (1) DE2203584A1 (enExample)
FR (1) FR2123479B1 (enExample)
GB (1) GB1330993A (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7071211B2 (en) * 2002-09-27 2006-07-04 Bausch & Lomb Inc. Small organic molecules that increase the activity of gelatinase a in ocular cells

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3108045A (en) * 1960-03-22 1963-10-22 Purdue Frederick Co Metal chelates of oxazolidinones as central nervous system stimulants

Also Published As

Publication number Publication date
AU3771772A (en) 1973-07-12
US3686409A (en) 1972-08-22
FR2123479A1 (enExample) 1972-09-08
AU461236B2 (en) 1975-05-22
GB1330993A (en) 1973-09-19
FR2123479B1 (enExample) 1975-02-07
CA964582A (en) 1975-03-18

Similar Documents

Publication Publication Date Title
EP0188810B1 (de) Verwendung von Dipeptidderivaten für die Herstellung von Arzneimitteln zur Verhinderung oder Behandlung posttraumatischer Nervenschäden nach unfallbedingten Rückenmarks- und/oder Gehirntraumen
DE60132444T2 (de) Behandlung von reizkolon-syndrom oder -krankheit
DE69027220T2 (de) Zusammensetzung und verfahren zur behandlung von schmerzvollen entzündlichen oder allergischen erkrankungen
DE3116860C2 (enExample)
Basmajian et al. Effect of Largactil (Chlorpromazine) on Human Spasticity and Electromyogram: Preliminary Report
DE2350721A1 (de) Neues, in der ophthalmologie einsetzbares medikament
DE19726871C1 (de) Synergistisch wirkende Zusammensetzungen zur selektiven Bekämpfung von Tumorgewebe
DE2203584A1 (de) Arzneimittel zur Bekaempfung der Parkinsonschen Krankheit
EP0018550B1 (de) Mittel zur Behandlung von Muskelerkrankungen
DE69625210T2 (de) Nicorandil gegen angstneurosen
McLellan The suppression of involuntary movements with tetrabenazine
CH660303A5 (de) Analgetische praeparate.
DE3116859A1 (de) Therapeutische zubereitungen fuer die behandlung einer tardiven dyskinesie
DD300508A5 (de) Verfahren zur Herstellung eines pharmazentischen präparates
WO2002007713A2 (de) Cilansetron enthaltende arzneimittel zur behandlung nicht-obstipativer männlicher ibs-patienten
DE2352618A1 (de) Arzneimittel zur behandlung des parkinsonismus
DE3404316C1 (de) Lorazepam-haltiges Schlafmittel
US2646385A (en) Pharmaceutical product for dysmenorrhea
DE2712662A1 (de) Zubereitung fuer die behandlung von seborrhoea bei hunden
DE3440140C2 (de) Verwendung von Thiamphenicol gegen die Gewöhnung an zentral wirkende Analgetika
DE2532180C2 (de) Verwendung von Etozolin bei der Bekämpfung der Hypertonie
DE1617508C3 (de) Antidepressive Mittel
DE3872571T2 (de) Mischung mit einem gehalt an einem zentralanalgetikum und forskolin als wirkstoffe.
DE3317280C2 (enExample)
DE1792282B1 (de) Antivirusmittel